🔗 Share this article

A shadow market for unapproved slimming medications is propelled by social media fitness personalities and vendors on communication apps, according to recent findings.

Experimental Drug Acquiring Traction Via Social Media

The experimental drug, which remains in clinical trials, is being advertised by online personalities for its alleged fat-burning effects. Followers are urged to message these profiles directly for supplier links, while also receiving discount codes.

Active Trade on Messaging Platforms

Separately, a robust trade exists on Telegram, where groups with numerous of members share comparison photos, administration instructions and claims of next-day British shipping. Vendors promote the substance there before directing buyers to WhatsApp for purchases.

Learning About Retatrutide

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Healthcare Experts Voice Worries

However, physicians and pharmacists have cautions that the sale of what remains an unlicensed medication in the United Kingdom is a cause for concern and could result in users administering substances of uncertain source.

Some professionals stated the demand for retatrutide could be connected to the increasing cost of licensed slimming treatments such as Mounjaro.

Legal Position and Enforcement

Selling the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unlicensed drug that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.

Several content creators try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still violate medicines, marketing, and consumer laws, risking fines, legal action or prison.

Service Reaction and Material Removal

Based on TikTok, the service has removed problematic content and prohibited related hashtags and query recommendations. The organization said it was dedicated to maintaining the platform safe and investing in strengthening compliance measures.

Online Trading Operations

Research also found groups with up to 9,000 members selling the experimental drug using Telegram's integrated search feature, which functions like a public directory. Typing “retatrutide” instantly displays groups with thousands of members, filled with photos of slimming results, glowing reviews and step-by-step guides for preparing or injecting at home.

Within moments of entering one group, a seller shared WhatsApp details, where the majority of transactions take place. The vendor provided an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None inquired about body mass, health issues or past usage.

Item Details and Pricing

Inside these groups, posts show dark colored parcels with postal service labels, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with sterile water, or pre-filled pens typically sold at £160 for 20mg. When asked how long a pen should be used, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Service Oversight and Security Measures

A representative for Telegram said it regularly moderated harmful content on its service including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are injecting materials they can’t verify. Although the research behind this drug is sound, these online versions may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the surge in demand to current cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are using online platforms. But counterfeit treatments are highly dangerous. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she explained.

Her staff has previously encountered patients harmed by personal administration from unconfirmed sources. “We recognize the frustration, but buying from Telegram or communication platforms is gambling with your well-being,” said the doctor. “These substances could be contaminated or incorrectly dosed.”

Producer Position

A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this point no one can market [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a Lilly investigational substance not yet authorized … may expose patients to potentially significant medical dangers”.